Senior woman header
Senior woman header
Photo header of senior man
Photo header of senior man

DIAGNOSTIC INSIGHTS FOR LIFE

CND has launched the Syn-One Test™ to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.

Learn More
Senior woman header
Senior woman header
Senior man header
Photo header of senior man

DIAGNOSTIC INSIGHTS FOR LIFE

CND has launched the Syn-One Test™ to offer physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy. And our mission has just begun.
Learn More

Introducing the Syn-One Test™ from CND Life Sciences

Offering physicians and patients an accurate, evidence-based tool to help confirm a diagnosis of a synucleinopathy.

seal icon

CLIA-Certified Pathology Lab

test tube icon

Dedication to Science & Research

DNA icon

Patient-Focused Mission

microscope icon

Quality & Reliability at Our Core

Clarity and Confidence of Syn-One

Having objective, visual proof of a disease process can be invaluable for physicians and patients. That’s why CND Life Sciences developed the Syn-One Test as a way to actually see the presence of abnormal alpha-synuclein in the skin–an important marker for Parkinson’s disease and other disorders known as synucleinopathies.  

Learn More

Our Commitment to Patients

We did not invent the saying “knowledge is power,” but we subscribe to this philosophy as part of our mission. Patients and caregivers rely on physicians to make vital clinical judgments every day, and we are committed to providing reliable diagnostic technologies and useful insights that help optimize care.

Learn more about what drives us.

Learn More

Read our perspectives on the industry, the field of neurodiagnostics, patient care, and other topics.

Insights
June 21, 2022

An Insider’s Perspective on Life at CND Life Sciences

Kendall Swanson started at CND Life Sciences as an intern in the summer before her…
Insights
June 14, 2022

Symptoms of Parkinson’s May Present 10 Years Before Diagnosis in Primary Care Setting

A large, population-based study of UK residents demonstrated that a variety of symptoms may be…
Insights
June 1, 2022

Limitations of DAT-SPECT in Diagnosis of Parkinson’s Disease

A recent case series report in Movement Disorders examines the potential limitations of dopamine transporter…
VIEW ALL INSIGHTS

Check out press releases, news alerts and coverage of CND happenings.

CND In the News
June 6, 2022

Alpha-Synuclein Detection Research Featured in Medscape Interview

Dr. Christopher H. Gibbons, Senior Scientific Advisor of CND Life Sciences, was recently interviewed in…
On Our Radar
May 26, 2022

Cutaneous Alpha-Synuclein Shown to Differentiate Parkinson’s From Related Neurological Disorders

A primary challenge in the diagnosis of neurological disorders is differentiating between conditions that share…
News Release
May 18, 2022

CND Life Sciences Awarded NIH SBIR Grant to Study Novel Skin Biopsy Test for Dementias

CND Life Sciences, an innovative medical diagnostics company pioneering the detection, visualization, and quantification of…
VIEW ALL NEWS
CND CASE STUDIES

For Clinicians: Request a Syn-One Test™ Kit

The Syn-One Test provides objective pathological evidence to aid in the diagnosis of a synucleinopathy. Simply collect three small punch skin biopsies from your patient, send them to our CLIA-certified lab, and CND Life Sciences will provide important visual insights to support a diagnosis. If you are a clinician, click below to order a Syn-One Test Biopsy Kit.

Order a Kit